[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 144
Citations 0
Letters
December 26, 2012

Markers for Prediction of Cardiovascular Disease Risk—Reply

Author Affiliations

Author Affiliations: Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina (Drs Yeboah and Herrington) (jyeboah@wakehealth.edu); and Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Greenland).

JAMA. 2012;308(24):2561-2562. doi:10.1001/jama.2012.25796

In Reply: Our study showed the superiority of CAC for improving discrimination for incident CHD and CVD in individuals classified as intermediate risk by the Framingham risk score. We agree with Dr Kavousi and colleagues that contemporary CHD risk prediction models such as the Framingham risk score are not necessarily optimized to also predict CVD, which typically includes cerebrovascular outcomes in the composite definition. This is an important limitation to bear in mind as the scientific and clinical communities seek to broaden the scope of vascular disease outcomes that are targeted by prediction and prevention measures.

First Page Preview View Large
First page PDF preview
First page PDF preview
×